moxisylyte has been researched along with Meniere Disease in 2 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
Meniere Disease: A disease of the inner ear (LABYRINTH) that is characterized by fluctuating SENSORINEURAL HEARING LOSS; TINNITUS; episodic VERTIGO; and aural fullness. It is the most common form of endolymphatic hydrops.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Young, JR | 2 |
2 other studies available for moxisylyte and Meniere Disease
| Article | Year |
|---|---|
Acetylator status and liver function profile changes in labyrinthine ischaemia patients treated with thymoxamine.
Topics: Acetylation; Adult; Aged; Ear, Inner; Female; Humans; Ischemia; Liver Function Tests; Male; Meniere | 1980 |
Retrospective assessment of thymoxamine (Opilon) in treatment of Ménières disease.
Topics: Drug Evaluation; Female; Humans; Male; Meniere Disease; Moxisylyte; Retrospective Studies | 1978 |